Contribution of donor-specific antibodies to acute allograft rejection: Evidence from B cell-deficient mice

Transplantation

Volumn 65, Issue 11, 1998, Pages 1489-1493

  Brändle, Daniel ^a   Joergensen, Joanne ^a   Zenke, Gerhard ^a   Bürki, Kurt ^a   Hof, Robert P ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL COMPARTMENTALIZATION; EFFECTOR CELL; GENE DISRUPTION; GENE TARGETING; GRAFT REJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE ACTIVATION; XENOGRAFT;

ANIMALS; B-LYMPHOCYTES; CYCLOSPORINE; GENE TARGETING; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE SERA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN MU-CHAINS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032525891     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00014     Document Type: Article

References (26)

1. Miller JFAP. Role of the thymus in transplantation immunity. Ann NY Acad Sci 1962; 99: 340.
2. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. J Exp Med 1978; 148: 878.
3. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996; 62: 303.
4. Manning DD, Jutila JW. Effect of anti-immunoglobulin antisera on homograft rejection in mice. Nature (New Biology) 1972; 237: 58.
5. Cerny A, Ramseier H, Bazin H, Zinkernagel RM. Unimpaired first-set and second-set skin graft rejection in agammaglobulinemic mice. Transplantation 1988; 45: 1111.
6. Auchincloss JHR, Ghobrial RM, Russell PS, Winn HJ. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation 1988; 45: 1118.
7. Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 1995; 182: 915.
8. Alexander DZ, Pearson TC, Hendrix R, Ritchie SC, Larsen CP. Analysis of effector mechanisms in murine cardiac allograft rejection. Transplant Immunol 1996; 4: 46.
9. Gracie JA, Bolton EM, Porteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172: 1547.
10. + T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 1993; 23: 2078.
11. Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ, chain gene. Nature 1991; 350: 423.
12. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
13. Borel JF Feurer C, Gubler HU, Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976; 6: 468.
14. Reem GH, Cook LA, Vilcek J. Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science 1983; 221: 63.
15. + T cell activation and tolerance induction in B cell knockout mice. J Exp Med 1996; 183: 1339.
16. Wolf SD, Dittel BN, Hardardottir F, Janeway CA. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996; 184: 2271.
17. Vella AT, Scherer MT, Shultz L, Kappler JW, Marrack P. B cells are not essential for peripheral T-cell tolerance. Proc Natl Acad Sci USA 1996; 93: 951.
18. Di Rosa F, Matzinger P. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med 1996; 183: 2153.
19. Asano MS, Ahmed R. CD8 T cell memory in B cell-deficient mice. J Exp Med 1996; 183: 2165.
20. Brundler MA, Aichele P, Bachmann M, Kitamura D, Rajewsky K, Zinkernagel RM. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Eur J Immunol 1996; 26: 2257.
21. null mice. J Exp Med 1996; 184: 2049.
22. Metlay JP, Pure E, Steinman RM. Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J Exp Med 1989; 169: 239.
23. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; II: 662.
24. Martin S, Dyer PA, Mallick NP, Gokal R, Harris R, Johnson RWG Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44: 50.
25. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. Transplantation 1992; 53: 550.
26. Lobo PI, Spencer CE, Stevenson WC, Pruett TL. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin. Transplantation 1995; 59: 357.